Log In
Print
BCIQ
Print
Print this Print this
 

glembatumumab vedotin (CDX-011) (formerly CR011-vcMMAE)

Also known as: formerly CR011

  Manage Alerts
Collapse Summary General Information
Company Celldex Therapeutics Inc.
DescriptionHuman mAb against glycoprotein NMB (GPNMB) linked to the tubulin inhibitor monomethyl auristatin E (MMAE)
Molecular Target Glycoprotein NMB (GPNMB) ; Tubulin
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today